Onesource Specialty Pharma
ONESOURCE · Pharma > Pharmaceuticals & Drugs Listing date: Jan. 24, 2025

Stock Price vs Company Growth
1d
0.5%
1w
4.0%
1m
1.9%
3m
35.8%
6m
10.3%
1y
0.7%
all
3.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,793 0.5%
1,231
1,915
Company Overview

Sales
1,422 Cr
Growth: 17.7%
Profit after Tax
-73.8 Cr
Growth: -467.3%
Mid Cap
20,554 Cr
P/S: 14.5x
Industry P/S: 2.5x
Fundamentals

Sales (Cr) ₹ 1,422
Growth 17.7%
EBITDA 21.4%
P/S 14.5x
Dividend 0.0%
P/E -278.0x
Book Value ₹ 509
PEG Ratio -15.7x
ROE -1.3%
P/B 3.5x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

OneSource Specialty Pharma is evolved into an integrated, multimodal specialty pharmaceutical CDMO. The company specialises in offering end-to-end solutions across biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatin capsules).Awards2024-25OneSource received the Sustainable Organisation Award 2025 at the 5th Sustainability Summit hosted by UBS Forums on June 11, 2025 in Gurgaon.Received ESG award in gold category from OHSSAI Foundation.